PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1684412
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1684412
Transradial Access Devices Market size was valued at USD 2,509.43 Million in 2024, expanding at a CAGR of 7.90% from 2025 to 2032.
Transradial access (TRA) devices are a kind of medical tool and equipment designed to facilitate vascular access through the radial artery, typically at the wrist. These devices are engineered to ensure precision, safety, and efficiency while minimizing complications.
Transradial Access Devices Market- Market Dynamics
Increasing demand from cardiology & vascular medicine and advancement in device technology are expected to propel market demand
The rising prevalence of cardiovascular diseases (CVDs) along with the factors like aging populations, sedentary lifestyles, poor dietary habits, and higher rates of obesity and diabetes. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide. With more patients requiring diagnostic and interventional cardiac procedures, the demand for TRA devices is growing. Minimally invasive procedures are widely used in healthcare due to their reduced morbidity, shorter hospital stays, and quicker patient recovery. TRA aligns with this trend by offering a safer and more comfortable alternative to TFA, particularly in patients at higher risk of bleeding complications. The increasing focus on patient-centric care and value-based healthcare models is driving the adoption of TRA.
Further, rising innovations in TRA devices have significantly improved procedural safety, efficacy, and ease of use. TRA is increasingly preferred over transfemoral access (TFA) for many vascular procedures due to its lower complication rates and enhanced patient comfort. This shift in clinical practice, along with advancements in device design and increasing procedural volumes, has driven the demand for TRA devices globally.
Transradial Access Devices Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.90% over the forecast period (2025-2032)
Based on Product Type segmentation, the catheters segment was predicted to show maximum market share in the year 2024, owing to the high demand for minimally invasive procedures.
Based on Application segmentation, the drug development segment was the leading application segment in 2024, owing to the rising prevalence of chronic disease.
Based on End User segmentation, the hospital segment was the leading End User segment in 2024, due to the availability of advanced medical facilities.
On the basis of region, North America was the leading revenue generator in 2024, owing to presence of well-established healthcare infrastructure.
The Global Transradial Access Devices Market is segmented on the basis of Product Type, Application, End User, and Region.
The market is divided into two categories based on Product Type: catheters and guidewires. The catheters segment dominates the market. High demand for catheters from diagnostic testing is expected to expand market growth.
The market is divided into three categories based on the Application: drug development, diagnostics & testing, and blood transfusion. The drug development segment is expected to hold the largest share owing to the high demand for diagnostic procedures.
The market is divided into three categories based on End User: hospitals, clinics, and others. The hospitals segment holds the largest share in the end user segment. The increasing demand from hospital healthcare systems for invasive procedures is expected to fuel segment growth.
Transradial Access Devices Market- Geographical Insights
Across the world, the transradial access devices market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds the largest share of the TRA devices market due to the high prevalence of CVDs, advanced healthcare infrastructure, and early adoption of innovative medical technologies. The Asia Pacific region is anticipated to grow at the highest rate over the forecast period. India, China, and Japan are leading in the global market with expanding healthcare infrastructure and growing numbers of interventional cardiologists adopting TRA techniques. Further, these devices are increasingly preferred over transfemoral access (TFA) due to their lower complication rates, reduced recovery times is also supplementing market growth.
The Transradial Access Devices market is characterized by intense competition among key players striving to enhance their market share through product innovation, strategic partnerships, and mergers and acquisitions. Companies are focusing on introducing advanced EPDs with improved efficacy and safety profiles. For instance, the development of next-generation devices featuring enhanced filter designs and reduced profile sizes aims to facilitate easier navigation through complex anatomies and provide better protection during procedures. Collaborations between medical device manufacturers and research institutions are fostering innovation and accelerating the development of cutting-edge embolic protection technologies.
In January 2024, AngioDynamics got US FDA clearance for Auryon XL catheter for peripheral artery disorders.
In November 2023, Cordis introduced the SMART Radianz stent system to enhance patient safety & efficacy.